News summary
[Watson Biologyluckyacepoker: We will continue to promote the sinking of the domestic market for bivalent HPV vaccine products] Securities Times e Company NewsluckyacepokerWatson Biotech (300142) recently stated that the company is currently carrying out WHO pre-certification work for bivalent HPV vaccines and simultaneously promoting cooperation projects with some countries.luckyacepoker.luckyacepoker..
Newsletter text
[Watson Biotech: Will continue to promote the sinking of the domestic market of bivalent HPV vaccine products] Securities Times e Company News, Watson Biotech (300142) recently stated that the company is currently carrying out WHO pre-certification work for bivalent HPV vaccines, and simultaneously promote cooperation projects with some countries and strive to realize the export of this product as soon as possible. In addition, recently, the company has continuously strengthened consumer education for school-age women to be vaccinated with bivalent HPV vaccines by building platforms with multiple public welfare partners. In the future, the company will continue to promote the sinking of the domestic market of bivalent HPV vaccine products and continue to promote the benefit of the people. Market, public welfare projects, and strive to gain an ideal market share in government procurement for the benefit of the people in 2024. The sales price of the company's products will be comprehensively determined based on market demand, specific bidding project conditions and market competition.